DigiPath's Dr. Cindy Orser Speaks on the Importance of Adopting Cannabis Standards August 14, 2014

LAS VEGAS, Aug. 5, 2014 /PRNewswire/ -- DigiPath, Inc. (OTCBB andOTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into the cannabis testing and education markets, announced today that Cindy Orser, Ph.D. will lead an introductory webinar on the importance of standards in the cannabis industry on Thursday, August 14, 2014. The key issue of adopting standards is the second in a five-week series of webinars collectively titled: "Cannabis 2.0: Making It in the Emerging Marijuana Industry," which begins on August 7^th.

As Chief Science Officer at DigiPath, Dr. Orser is creating a replicable testing environment with validated protocols to ensure cannabis and cannabis-based products are safe. She will also be developing standards and biomarkers to clearly distinguish products derived from specific cannabis strains concomitant with determining the bioavailability of the cannabinoids found in the product.

A serial entrepreneur, Dr. Orser has launched five small biotech ventures during the last ten years. These ventures include Big Sky Biosystems Inc., which offers scientific, technical, regulatory and strategic affairs consulting to the molecular and medical diagnostics industry, and CB Cures LLC, which was working to develop novel formulations of cannabis extracts for clinical endpoints and a THC biosensor for roadside sobriety testing.

During her hour-long presentation, Dr. Orser will discuss how the chemical composition of each strain of cannabis varies, and how each plant's cannabinoid and terpenoid profiles may be beneficial in relieving symptoms associated with chronic disease. She will also examine the need for setting industry standards and processes for cultivating cannabis, converting cannabis to cannabis-based products, and testing cannabis and cannabis-based products.

"Many people are looking for an opportunity to benefit from a wave of recent legal victories in the cannabis market, but most people don't know what to do," said Mike "Zappy" Zapolin, Cannabis 2.0's host and moderator of this year's Milken Global Conference panel titled The Highs and Lows of the Cannabis Economy. "This course gives them the tools they need to immediately jump in and be successful."

Zapolin points out that for the majority of the last century, prohibition kept cannabis underground, but now, the industry is shifting away from people who were willing to break the law and sell drugs for cash to licensed companies with banking relationships and publicly traded stocks. And it's not just entrepreneurs—scientists, doctors, and seasoned business executives are increasingly entering the industry as cannabis commerce relocates from dark alleyways to Main Street.

"Dr. Orser's webinar is a great way for people to meet her and learn about our work to improve the cannabis industry," said Steve Barbee, CEO of DigiPath, Inc. "We strongly believe education holds the key to its transformation, and we are set to lead the industry on that front."

For more information about the series, go to: http://evolverlearninglab.com/products/cannabis-2-0-making-it-in-the-emerging-marijuana-industry.

About DigiPath, Inc.

DigiPath, Inc., develops and markets affordable and accurate human and animal digital pathology solutions. The company is rapidly expanding into the botanical, nutraceutical, and cannabis industries with industry-leading testing, and education and training services.

For more information, go to: www.digipath.com and www.digipath.biz.

Information about Forward-Looking Statements

This press release contains "forward-looking statements" that include information relating to future events and future financial and operating performance. The words "may," "might," "would," "will," "expect," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for the Company's products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. An example of such forward looking statements in this press release include statements regarding the Company developing and completing new products and revenue growth. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
DigiPath, Inc
Investor Relations
888-552-4440
[email protected]

Photo - http://photos.prnewswire.com/prnh/20140605/94753

SOURCE DigiPath.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED